• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

- 相关帕金森病的小鼠模型中的行为表型。

Behavioral Phenotyping in a Murine Model of -Associated Parkinson Disease.

机构信息

Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Int J Mol Sci. 2021 Jun 25;22(13):6826. doi: 10.3390/ijms22136826.

DOI:10.3390/ijms22136826
PMID:34202076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8267726/
Abstract

Mutations in , the gene encoding glucocerebrosidase, are common genetic risk factors for Parkinson disease (PD). While the mechanism underlying this relationship is unclear, patients with -associated PD often have an earlier onset and faster progression than idiopathic PD. Previously, we modeled -associated PD by crossing haploinsufficient mice with mice overexpressing a human mutant α-synuclein transgene (), observing an earlier demise, shorter life span and faster symptom progression, although behavioral testing was not performed. To assess whether // mice exhibit a prodromal behavioral phenotype, we studied three cardinal PD features: olfactory discrimination, memory dysfunction, and motor function. The longitudinal performance of // ( = 8), ( = 9), ( = 10) and wildtype ( = 6) mice was evaluated between ages 8 and 23 months using the buried pellet test, novel object recognition test and the beam walk. Fifteen-month-old // mice showed more olfactory and motor deficits than wildtype mice. However, differences between // and mice generally did not reach statistical significance, possibly due to small sample sizes. Furthermore, while haploinsufficiency leads to a more rapid demise, this might not result in an earlier prodromal stage, and other factors, including aging, oxidative stress and epigenetics, may contribute to the more fulminant disease course.

摘要

基因突变 ,编码葡萄糖脑苷脂酶的基因,是帕金森病(PD)的常见遗传风险因素。虽然这种关系的机制尚不清楚,但与 -相关的 PD 患者的发病通常比特发性 PD 更早且进展更快。以前,我们通过将半合子不足的小鼠与过度表达人类突变α-突触核蛋白转基因()的小鼠杂交来模拟 -相关的 PD,观察到更早的死亡、更短的寿命和更快的症状进展,尽管未进行行为测试。为了评估 // 小鼠是否表现出前驱性行为表型,我们研究了三种主要的 PD 特征:嗅觉辨别、记忆功能障碍和运动功能。通过埋藏颗粒测试、新物体识别测试和梁行走,在 8 至 23 个月龄之间评估了 // ( = 8)、( = 9)、( = 10)和野生型( = 6)小鼠的纵向表现。15 个月大的 // 小鼠比野生型小鼠表现出更多的嗅觉和运动缺陷。然而,// 和 小鼠之间的差异通常没有达到统计学意义,可能是由于样本量较小。此外,尽管 // 半合子不足导致更快的死亡,但这可能不会导致更早的前驱期,其他因素,包括衰老、氧化应激和表观遗传学,可能会导致更严重的疾病进程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c42/8267726/f5e7714dc5f3/ijms-22-06826-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c42/8267726/efbae151d9b1/ijms-22-06826-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c42/8267726/6aa209981c19/ijms-22-06826-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c42/8267726/d83a8f72a2dc/ijms-22-06826-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c42/8267726/f5e7714dc5f3/ijms-22-06826-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c42/8267726/efbae151d9b1/ijms-22-06826-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c42/8267726/6aa209981c19/ijms-22-06826-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c42/8267726/d83a8f72a2dc/ijms-22-06826-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c42/8267726/f5e7714dc5f3/ijms-22-06826-g004.jpg

相似文献

1
Behavioral Phenotyping in a Murine Model of -Associated Parkinson Disease.- 相关帕金森病的小鼠模型中的行为表型。
Int J Mol Sci. 2021 Jun 25;22(13):6826. doi: 10.3390/ijms22136826.
2
Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course.A53Tα-突触核蛋白小鼠糖脑苷脂酶单倍体不足影响疾病的发病和进程。
Mol Genet Metab. 2017 Dec;122(4):198-208. doi: 10.1016/j.ymgme.2017.11.001. Epub 2017 Nov 21.
3
Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.转 Gaucher 突变杂合子帕金森病小鼠表型增强。
Brain. 2014 Dec;137(Pt 12):3235-47. doi: 10.1093/brain/awu291. Epub 2014 Oct 27.
4
Glucocerebrosidase modulates cognitive and motor activities in murine models of Parkinson's disease.葡萄糖脑苷脂酶调节帕金森病小鼠模型中的认知和运动活动。
Hum Mol Genet. 2016 Jul 1;25(13):2645-2660. doi: 10.1093/hmg/ddw124. Epub 2016 Apr 28.
5
Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models.葡糖神经酰胺合酶抑制可减轻突触核蛋白病模型中的异常情况。
Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):2699-2704. doi: 10.1073/pnas.1616152114. Epub 2017 Feb 21.
6
Silencing of Glucocerebrosidase Gene in Enhances the Aggregation of Parkinson's Disease Associated α-Synuclein Mutant A53T and Affects Locomotor Activity.葡萄糖脑苷脂酶基因沉默增强帕金森病相关α-突触核蛋白突变体A53T的聚集并影响运动活性。
Front Neurosci. 2018 Feb 16;12:81. doi: 10.3389/fnins.2018.00081. eCollection 2018.
7
Neuropsychiatric characteristics of GBA-associated Parkinson disease.GBA相关帕金森病的神经精神特征
J Neurol Sci. 2016 Nov 15;370:63-69. doi: 10.1016/j.jns.2016.08.059. Epub 2016 Aug 30.
8
GBA haploinsufficiency accelerates alpha-synuclein pathology with altered lipid metabolism in a prodromal model of Parkinson's disease.GBA 杂合子不足通过改变帕金森病前驱模型中的脂质代谢加速α-突触核蛋白病理。
Hum Mol Genet. 2019 Jun 1;28(11):1894-1904. doi: 10.1093/hmg/ddz030.
9
GBA deficiency promotes SNCA/α-synuclein accumulation through autophagic inhibition by inactivated PPP2A.GBA缺乏通过失活的PPP2A抑制自噬来促进SNCA/α-突触核蛋白的积累。
Autophagy. 2015;11(10):1803-20. doi: 10.1080/15548627.2015.1086055.
10
D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model.D409H GBA1 突变加速 A53T α-突触核蛋白转基因小鼠模型的病理学进展。
Acta Neuropathol Commun. 2018 Apr 27;6(1):32. doi: 10.1186/s40478-018-0538-9.

引用本文的文献

1
Neural and vascular contributions to sensory impairments in a human alpha-synuclein transgenic mouse model of Parkinson's disease.在帕金森病的人α-突触核蛋白转基因小鼠模型中,神经和血管对感觉障碍的影响
J Cereb Blood Flow Metab. 2025 May 7:271678X251338952. doi: 10.1177/0271678X251338952.
2
Synaptic and cognitive impairment associated with L444P heterozygous glucocerebrosidase mutation.与L444P杂合性葡萄糖脑苷脂酶突变相关的突触和认知障碍。
Brain. 2025 May 13;148(5):1621-1638. doi: 10.1093/brain/awae380.
3
Human midbrain organoids: a powerful tool for advanced Parkinson's disease modeling and therapy exploration.

本文引用的文献

1
Penetrance of Glucocerebrosidase (GBA) Mutations in Parkinson's Disease: A Kin Cohort Study.帕金森病中葡萄糖脑苷脂酶(GBA)突变的外显率:一项近亲队列研究。
Mov Disord. 2020 Nov;35(11):2111-2114. doi: 10.1002/mds.28200. Epub 2020 Aug 7.
2
The role of genetics in Parkinson's disease: a large cohort study in Chinese mainland population.遗传学在帕金森病中的作用:中国大陆人群的一项大型队列研究。
Brain. 2020 Jul 1;143(7):2220-2234. doi: 10.1093/brain/awaa167.
3
β-Glucocerebrosidase activity in -linked Parkinson disease: The type of mutation matters.
人源中脑类器官:用于帕金森病高级建模和治疗探索的强大工具。
NPJ Parkinsons Dis. 2024 Oct 20;10(1):189. doi: 10.1038/s41531-024-00799-8.
4
How Well Do Rodent Models of Parkinson's Disease Recapitulate Early Non-Motor Phenotypes? A Systematic Review.帕金森病啮齿动物模型对早期非运动表型的模拟效果如何?一项系统评价。
Biomedicines. 2022 Nov 24;10(12):3026. doi: 10.3390/biomedicines10123026.
5
Deep phenotyping for precision medicine in Parkinson's disease.深度表型分析在帕金森病精准医学中的应用。
Dis Model Mech. 2022 Jun 1;15(6). doi: 10.1242/dmm.049376.
- 连接型帕金森病中β-葡糖脑苷脂酶活性:突变类型很重要。
Neurology. 2020 Aug 11;95(6):e685-e696. doi: 10.1212/WNL.0000000000009989. Epub 2020 Jun 15.
4
Glycosphingolipids and lysosomal storage disorders as illustrated by gaucher disease.糖鞘脂类和溶酶体贮积症,以戈谢病为例。
Curr Opin Chem Biol. 2019 Dec;53:204-215. doi: 10.1016/j.cbpa.2019.10.006. Epub 2019 Nov 26.
5
Glucocerebrosidase and its relevance to Parkinson disease.葡萄糖脑苷脂酶及其与帕金森病的关系。
Mol Neurodegener. 2019 Aug 29;14(1):36. doi: 10.1186/s13024-019-0336-2.
6
Age-related neurochemical and behavioural changes in D409V/WT GBA1 mouse: Relevance to lewy body dementia.D409V/WT GBA1 小鼠的年龄相关性神经化学和行为变化:与路易体痴呆的相关性。
Neurochem Int. 2019 Oct;129:104502. doi: 10.1016/j.neuint.2019.104502. Epub 2019 Jul 9.
7
Can GBA1-Associated Parkinson Disease Be Modeled in the Mouse?GBA1 相关帕金森病能否在小鼠中建模?
Trends Neurosci. 2019 Sep;42(9):631-643. doi: 10.1016/j.tins.2019.05.010. Epub 2019 Jul 6.
8
Evolution and clustering of prodromal parkinsonian features in GBA1 carriers.GBA1 携带者前驱帕金森特征的演变和聚类。
Mov Disord. 2019 Sep;34(9):1365-1373. doi: 10.1002/mds.27775. Epub 2019 Jun 28.
9
Evolution of prodromal parkinsonian features in a cohort of mutation-positive individuals: a 6-year longitudinal study.队列研究中突变阳性个体前驱帕金森特征的演变:一项 6 年纵向研究。
J Neurol Neurosurg Psychiatry. 2019 Oct;90(10):1091-1097. doi: 10.1136/jnnp-2019-320394. Epub 2019 Jun 20.
10
Fetal gene therapy for neurodegenerative disease of infants.婴儿神经退行性疾病的胎儿基因治疗。
Nat Med. 2018 Sep;24(9):1317-1323. doi: 10.1038/s41591-018-0106-7. Epub 2018 Jul 16.